News
UGA Researchers Develop Synthetic HDL Cholesterol Nanoparticles
May 14, 2013 10:28 am | by Alan Flurry, Franklin College of Arts and Sciences | CommentsAtherosclerosis, a buildup of cellular plaque in the arteries, remains one of the leading causes of death globally. While high-density lipoprotein, or HDL, the so-called good cholesterol, is transferred to the liver for processing, low-density lipoprotein, or LDL, builds up in the arteries in the form of plaque.
Digital Mammography Cancer Detection Rates May Vary Significantly
May 14, 2013 10:03 am | by Radiological Society of North America | CommentsDigital direct radiography is significantly more effective than computed radiography at detecting breast cancer, according to a new study published online in the journal Radiology. The findings are the first to show a difference between the two types of digital imaging when compared with screen film mammography and suggest that women should be informed of the potential for lower cancer detection with CR, the researchers said.
Stryker Receives Top Supplier Awards From Novation
May 14, 2013 9:41 am | by The Associated Press | CommentsStryker's Sustainability Solutions division announced today it has received two prestigious awards from the group purchasing organization Novation for supplier excellence. Novation named Stryker's reprocessing division Purchased Services Supplier of the Year and presented it with top honors in...
Olympus Endoscopes Now Powered by Next-Generation Ultrasound Processor
May 14, 2013 9:12 am | by The Associated Press | CommentsOlympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that the Company's ultrasound endoscopes will now be powered by the ProSound F75 Ultrasound Processor.
EndoGastric Solutions® Unveils New Research Demonstrating the Benefits of Transoral Incisionless Fundoplication (TIF®) vs. Maximum PPI Therapy
May 14, 2013 9:00 am | by The Associated Press | CommentsREDWOOD CITY, Calif.--(BUSINESS WIRE)--May 14, 2013--EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for Gastroesophageal Reflux Disease (GERD), today announced the presentation of randomized controlled trial data and key educational activities taking place at...
Lieff Cabraser Announces Class Action Litigation Against Intuitive Surgical, Inc.
May 14, 2013 9:00 am | by The Associated Press | CommentsSAN FRANCISCO--(BUSINESS WIRE)--May 14, 2013--The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of all persons who purchased or otherwise acquired the securities of Intuitive Surgical, Inc. (“Intuitive” or the “Company”)...
NVISION Laser Eye Centers First in the Nation to Offer Avellino-GENE Detection System Test to Protect Patients from Blindness
May 14, 2013 8:04 am | by PR Newswire | CommentsMENLO PARK, Calif., May 14, 2013 /PRNewswire/ -- Avellino Lab USA, developer of the only genetic test available worldwide for Avellino Corneal Dystrophy (ACD), today announced that California-based NVISION Laser Eye Centers is the first provider in the United States to offer patients...
Vocera® Ranked Number One in Wireless Communications for Healthcare
May 14, 2013 8:03 am | by PR Newswire | CommentsSAN JOSE, Calif., May 14, 2013 /PRNewswire/ -- Vocera Communications, Inc. (NYSE: VCRA), the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced findings...
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
May 14, 2013 8:00 am | by The Associated Press | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--May 14, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced enrollment of the first patient in the EnligHTN III trial. This study will evaluate the safety and performance of the new second-generation EnligHTN ™ Renal...
The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering
May 13, 2013 4:30 pm | by PR Newswire | CommentsSYDNEY, May 13, 2013 /PRNewswire/ -- The University of Sydney and ResMed Limited today announced a new partnership that includes significant and long-term funding of research at the University, ultimately benefitting the hundreds of millions of sufferers of sleep-disordered breathing worldwide.
Breakthrough ‘AffloVest’ Greatly Advances Respiratory Care
May 13, 2013 1:46 pm | by International Biophysics Corporation | CommentsA new high frequency chest wall oscillation vest that gives respiratory patients the freedom to move around during treatments is now available in the United States, International Biophysics Corporation has announced. The AffloVest represents a major advancement in the treatment of respiratory diseases such as Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, chronic bronchitis, and similar related ailments.
Anaesthetists’ Survey Delivers Food for Thought
May 13, 2013 1:23 pm | by Creative Medical Research | CommentsA recent Europe-wide survey of Anaesthetists has revealed a range of issues affecting the profession in relation to existing and future technologies. The 15-minute long survey of 104 anaesthetists from western, northern and southern Europe asked a number of pertinent questions concerning the nature of current technologies and those expected to come on stream in the near future.
The Smart Phone App that Helps Weight Loss
May 13, 2013 12:28 pm | by The University of Liverpool | CommentsResearchers at the University of Liverpool have developed a smart phone app that helps users lose weight by carefully recording their food consumption. The app was developed in response to research from the University’s Institute of Psychology, Health and Society, which showed that paying attention to what you eat while you eat it helps reduce food intake and prevents consuming excess calories at future meals.
Extremely Low 90-Day Cardiac Device Infection Rates with TYRX Antibacterial Envelope Use
May 13, 2013 12:19 pm | by Kureczka/Martin Associates | CommentsUse of TYRX, Inc.'s AIGISRx Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device (CIED) replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013.
Reversing Paralysis with a Restorative Gel
May 13, 2013 12:15 pm | by Tel Aviv University | CommentsSome parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis.
